Weekly in Asia 20190609-0615
CStone and Bayer Collaborates to Evaluate Combination Therapy with PD-L1 Monoclonal Antibody CS1001 and Regorafenib On June 10th, CStone Pharmaceuticals and Bayer HealthCare announced global collaboration to evaluate PD-L1 monoclonal …
Read More